Rare-disease drug developer (hereditary angioedema)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 56 | New buy | 848,336 | $8,483,360 | 0.1% |
| Bridgewater | 55 | Trimmed -23% | 491,057 | $4,910,570 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-16.